RecruitingAlzheimer Disease
A Study of LY3439539 in Participants With Alzheimer's Disease
Eligible age
50–85 yrs
Accepts
All genders
Locations
3 states
Healthy volunteers
No
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
The purpose of this study is to see how LY3439539 affects certain proteins found in the spinal fluid of participants with Alzheimer's disease. Participation in the study will last approximately 9 months with visits about once a month.
Sponsor: Eli Lilly and Company
You may qualify if…
- ✓ Have gradual and progressive change in memory function reported by the participant or informant for 6 months or longer consistent with a diagnosis of dementia due to Alzheimer's disease
- ✓ Have a Mini Mental Score Examination score of 16 to 24, inclusive
- ✓ Meet plasma pTau criteria, as defined by the sponsor
- ✓ Have body mass index within the range of 17 and 32 kilograms per square meter (kg/m²) (inclusive) at screening
- ✓ Are women not of childbearing potential and men willing to practice effective contraception throughout the study.
- ✓ Have adequate premorbid literacy, vision, and hearing throughout the study duration and able to complete study procedures.
- ✓ Have at least 1, and up to 2, study partners who are in frequent contact with the participant (defined as at least 10 hours per week).
You may not qualify if…
- ✕ Have any contraindications for magnetic resonance imaging (MRI), including claustrophobia or the presence of contraindicated metal (ferromagnetic) implants/cardiac pacemaker.
- ✕ Have a screening MRI that shows evidence of significant abnormality.
- ✕ Have history of suicidal behavior, or a lifetime history of suicide attempt or acute suicidality.
- ✕ Have a history of
- ✕ Severe or ongoing allergy or hypersensitivity reactions
- ✕ Hypersensitivity to immunizations or immunoglobulins
- ✕ Two or more clinically significant or severe drug allergies,
- ✕ Intolerance to topical corticosteroids or severe posttreatment hypersensitivity reactions
Where it's recruiting
California
Irvine · Long Beach · Los Angeles · Oakland
Florida
Lady Lake · Maitland · Orlando
Michigan
Farmington Hills
Source: ClinicalTrials.gov · NCT07598370 · last updated 2026-11-04